EISAI FARMACEUTICA, Unipessoal Lda. secures contract for Direct Contracting For The Acquisition Of L1066 - Lenvatinib [10 Mg; Cap/ Comp] And L1067 - Lenvatinib [4 Mg; Cap/ Comp] To Meet Healthcare Needs

Portugal, Feb. 26 -- Portugal based EISAI FARMACEUTICA, Unipessoal Lda. has secured contract from Instituto Portugues De Oncologia Do Porto Francisco Gentil, Epe for Direct Contracting For The Acquisition Of L1066 - Lenvatinib [10 Mg; Cap/ Comp] And L1067 - Lenvatinib [4 Mg; Cap/ Comp] To Meet Healthcare Needs. The value of the contract is worth 235940 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....